Interferon alpha 2a therapy for urticarial vasculitis with angioedema apparently following hepatitis A infection.
A 68-year-old woman with a 5 yr history of chronic recurrent urticarial vasculitis with angioedema, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, nonsteroidal antiinflammatory agents, methotrexate, hydroxychloroquine, dapsone, azathioprine, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon alpha 2a. The cause of the urticarial vasculitis remains unknown, although its onset followed a hepatitis A infection. This is the first report of the successful use of interferon alpha for chronic urticarial vasculitis/angioedema.
Matteson
E L
EL
Mayo Clinic and Mayo Graduate School of Medicine, Rochester, MN 55905, USA.
D000368:Aged; D000799:Angioedema / Q000188:drug therapy* / Q000209:etiology; D002908:Chronic Disease; D005260:Female; D006506:Hepatitis A / Q000150:complications*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012008:Recurrence; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology; D014657:Vasculitis / Q000188:drug therapy* / Q000209:etiology
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins